Predictive Oncology Stock Alpha and Beta Analysis
| POAI Stock | USD 0.81 0.03 3.85% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Predictive Oncology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Predictive Oncology over a specified time horizon. Remember, high Predictive Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Predictive Oncology's market risk premium analysis include:
Beta 1.83 | Alpha (0.30) | Risk 5.85 | Sharpe Ratio (0.02) | Expected Return (0.11) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Predictive |
Predictive Oncology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Predictive Oncology market risk premium is the additional return an investor will receive from holding Predictive Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Predictive Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Predictive Oncology's performance over market.| α | -0.3 | β | 1.83 |
Predictive Oncology expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Predictive Oncology's Buy-and-hold return. Our buy-and-hold chart shows how Predictive Oncology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Predictive Oncology Market Price Analysis
Market price analysis indicators help investors to evaluate how Predictive Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Predictive Oncology shares will generate the highest return on investment. By understating and applying Predictive Oncology stock market price indicators, traders can identify Predictive Oncology position entry and exit signals to maximize returns.
Predictive Oncology Return and Market Media
The median price of Predictive Oncology for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 0.77 with a coefficient of variation of 14.33. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 0.77, and mean deviation of 0.09. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Predictive Oncology faces NASDAQ delisting over share price - Investing.com | 09/20/2024 |
2 | Insider Trading | 10/04/2024 |
3 | Acquisition by Hawryluk Matthew of 18360 shares of Predictive Oncology subject to Rule 16b-3 | 11/04/2024 |
4 | Enovis Q3 Earnings and Revenues Beat Estimates | 11/06/2024 |
5 | Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update | 11/13/2024 |
6 | Acquisition by Chung-welch Nancy of 2675 shares of Predictive Oncology subject to Rule 16b-3 | 11/27/2024 |
About Predictive Oncology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Predictive or other stocks. Alpha measures the amount that position in Predictive Oncology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2024 (projected) | Payables Turnover | 0.48 | 0.54 | 0.31 | Days Of Inventory On Hand | 290.55 | 311.08 | 387.01 |
Predictive Oncology Upcoming Company Events
As portrayed in its financial statements, the presentation of Predictive Oncology's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Predictive Oncology's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Predictive Oncology's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Predictive Oncology. Please utilize our Beneish M Score to check the likelihood of Predictive Oncology's management manipulating its earnings.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Predictive Oncology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Predictive Oncology Backtesting, Predictive Oncology Valuation, Predictive Oncology Correlation, Predictive Oncology Hype Analysis, Predictive Oncology Volatility, Predictive Oncology History and analyze Predictive Oncology Performance. For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Predictive Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.